BioIVT × BeCytes Biotechnologies
The American multinational BioIVT announced the acquisition of BeCytes Biotechnologies, a spin-off of the University of Barcelona based at the Barcelona Science Park. BeCytes is a provider of high-quality human tissues and cells, with an expertise in primary human hepatic cells. The cost of the acquisition was not disclosed.
The asset
A company specializing in the coordination, processing, and distribution of high-quality human tissues and cells, particularly hepatic and pulmonary, for biomedical research.
The record
- Seller status
- Going concern
- Sector
- Biobank / Human tissue procurement
- Modalities
- biospecimens, cellular_products
- Jurisdiction
- ES
- Personal data
- Tissues and cells are ethically sourced.
What it means if you hold data
This acquisition expands BioIVT's global access to high-quality biological samples and strengthens its portfolio for preclinical research, particularly in liver and lung models. The deal addresses the growing demand for New Approach Methodologies (NAMs), which provide ethical alternatives to animal models in drug development.